Fig. 2: Overall efficacy and efficacy by tumor histology. | British Journal of Cancer

Fig. 2: Overall efficacy and efficacy by tumor histology.

From: Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma

Fig. 2

a lKaplan–Meier time to event curve for time to treatment failure (TTF) for all patients enrolled on study. b Kaplan–Meier curves showing the time to treatment failure for patients by histologic category showing the best outcome for adenoid cystic and thyroid cancer patients.

Back to article page